Lactulose is a synthetic disaccharide used commonly as a laxative in the treatment of constipation and constipation-related disorders such as portal systemic encephalopathy. It exerts laxative effects through its metabolism by colorectal bacteria into acids that help soften stools. The global lactulose market is estimated to be valued at US$ 856 million in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The preference for lactulose as an alternative constipation treatment over other conventional laxatives such as senna and bisacodyl has been a key trend driving market growth. Patients especially prefer lactulose for its natural working mechanism and relatively fewer side effects compared to stimulant laxatives. Its easy availability over the counter has also contributed to wider uptake amongst consumers looking for effective yet natural constipation relief. As awareness regarding risks of long-term usage of stimulant laxatives increases, demand for gentler alternatives such as lactulose is expected to witness consistent growth over the forecast period.
Segment Analysis
The Global lactulose market size is dominated by the oral segment. This segment accounts for the largest share owing to its high convenience of consumption. Lactulose in oral form such as syrup is commonly prescribed for constipation and hepatic encephalopathy. The tablet sub-segment is expected to grow the fastest during the forecast period due to rising demand for lactulose tablets with better portability and negligible odor.
Key Takeaways
The global lactulose market is expected to witness high growth during the forecast period due to rising cases of constipation, especially among geriatric population, and growing prevalence of liver-related disorders.
Regional analysis: North America currently dominates the global lactulose market and is expected to continue its dominance during the forecast period. This is attributed to the growing healthcare expenditure and availability of advanced treatment options for gut and liver diseases in the region. Asia Pacific is anticipated to be the fastest growing market for lactulose owing to the rising aging population, growing medical tourism, and improvement in healthcare infrastructure in emerging Asian countries.
Key players operating in the lactulose market are Abbott, Morinaga, Solactis, Fresenius Kabi, Illovo, and Biofac. Abbott dominates the global lactulose market with over 30% market share owing to its wide product portfolio and global sales network. Morinaga focuses on manufacturing medium chain triglycerides and prebiotics including lactulose via its Morinaga Milk biotechnology research and development system.
Get More Insights On This Topic: https://www.newsstatix.com/lactulose-market-size-share-analysis-2023-2030/
Comments
0 comment